These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 22261548)

  • 21. Initial experience with repetitive transarterial chemoembolization (TACE) as a third line treatment of ovarian cancer metastasis to the liver: indications, outcomes and role in patient's management.
    Vogl TJ; Naguib NN; Lehnert T; Nour-Eldin NE; Eichler K; Zangos S; Gruber-Rouh T
    Gynecol Oncol; 2012 Feb; 124(2):225-9. PubMed ID: 22079359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion.
    Monier A; Guiu B; Duran R; Aho S; Bize P; Deltenre P; Dunet V; Denys A
    Eur Radiol; 2017 Apr; 27(4):1431-1439. PubMed ID: 27436016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treating unresectable intrahepatic cholangiocarcinoma with transarterial chemoembolization and an unusual progression with cardiac involvement.
    Mumdzhiev N; Borisov B; Tenev R; Radicheva M
    Folia Med (Plovdiv); 2023 Apr; 65(2):326-330. PubMed ID: 37144321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transarterial chemoembolization plus lenvatinib with or without a PD-1 inhibitor for advanced and metastatic intrahepatic cholangiocarcinoma: a retrospective real-world study.
    Ning Z; Xie L; Yan X; Hua Y; Shi W; Lin J; Xu L; Meng Z
    Br J Radiol; 2023 Oct; 96(1150):20230079. PubMed ID: 37660471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results.
    Aliberti C; Benea G; Tilli M; Fiorentini G
    Cardiovasc Intervent Radiol; 2008; 31(5):883-8. PubMed ID: 18478290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-eluting bead transarterial chemoembolization (DEB-TACE) versus conventional transarterial chemoembolization (cTACE) in colorectal liver metastasis: Efficacy, safety, and prognostic factors.
    Zhang H; Wu C; Chen M; Sun Y; Han J
    J Cancer Res Ther; 2023 Dec; 19(6):1525-1532. PubMed ID: 38156918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative study of efficacy and safety of transarterial chemoembolization with CalliSpheres and conventional transarterial chemoembolization in treating unresectable intrahepatic cholangiocarcinoma patients.
    Sun T; Zhang W; Chen L; Ren Y; Liu Y; Zheng C
    J Cancer; 2022; 13(4):1282-1288. PubMed ID: 35281867
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemoembolization with Degradable Starch Microspheres for Treatment of Patients with Primary or Recurrent Unresectable, Locally Advanced Intrahepatic Cholangiocarcinoma: A Pilot Study.
    Goerg F; Zimmermann M; Bruners P; Neumann U; Luedde T; Kuhl C
    Cardiovasc Intervent Radiol; 2019 Dec; 42(12):1709-1717. PubMed ID: 31578633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of efficacy and safety of conventional transarterial chemoembolization and drug-eluting bead transarterial chemoembolization in unresectable intrahepatic cholangiocarcinoma: A multicenter retrospective cohort study.
    Zhang Z; Jiang N; Yin X; Xu A; Hao Y; Li H; Yang W; Mu K
    Eur J Radiol; 2024 Jul; 176():111541. PubMed ID: 38843693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy for transarterial chemoembolization in patients with unresectable hepatocellular carcinoma.
    Wu J; Song L; Zhao DY; Guo B; Liu J
    World J Gastroenterol; 2014 Aug; 20(31):10960-8. PubMed ID: 25152600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxaliplatin-eluting microspheres for the treatment of intrahepatic cholangiocarcinoma: a case report.
    Poggi G; Quaretti P; Minoia C; Palumbo I; Villani L; Amatu A; Teragni C; Scelsi M; Zappoli F; Bernardo G
    Anticancer Res; 2008; 28(5B):2987-90. PubMed ID: 19031944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma.
    Kang YJ; Lee BC; Kim JK; Yim NY; Kim HO; Cho SB; Jeong YY
    Cardiovasc Intervent Radiol; 2020 Jan; 43(1):55-64. PubMed ID: 31646378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-eluting bead transarterial chemoembolization (TACE) vs conventional TACE in treating hepatocellular carcinoma patients with multiple conventional TACE treatments history: A comparison of efficacy and safety.
    Li H; Wu F; Duan M; Zhang G
    Medicine (Baltimore); 2019 May; 98(21):e15314. PubMed ID: 31124925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting.
    Karalli A; Teiler J; Haji M; Seth E; Brismar TB; Wahlin S; Axelsson R; Stål P
    Scand J Gastroenterol; 2019 Jul; 54(7):905-912. PubMed ID: 31287338
    [No Abstract]   [Full Text] [Related]  

  • 35. Risk factors of liver abscess and biloma formation after drug-eluting bead transarterial chemoembolization for unresectable intrahepatic cholangiocarcinoma.
    Bian L; Yang J; Song Z
    Arab J Gastroenterol; 2024 May; 25(2):176-181. PubMed ID: 38388217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis.
    Liu BJ; Gao S; Zhu X; Guo JH; Kou FX; Liu SX; Zhang X; Wang XD; Cao G; Chen H; Liu P; Zhu LZ; Xu HF; Yang RJ
    Biomed Res Int; 2021; 2021():6670367. PubMed ID: 34337041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
    BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-eluting bead transarterial chemoembolization (TACE) exhibits superior efficacy and equal tolerance to conventional TACE in hepatocellular carcinoma patients with conventional TACE history.
    Tang J; Huang Z; Xu J; Lv Q; Wang P
    Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101814. PubMed ID: 34597848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transarterial Chemoembolization (TACE) Using Mitomycin with or without Irinotecan for Hepatocellular Carcinoma in European Patients.
    Gruber-Rouh T; Kamal A; Eichler K; Naguib NN; Beeres M; Langenbach M; Vogl TJ
    Oncol Res Treat; 2018; 41(7-8):438-442. PubMed ID: 30007958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver.
    Kirchhoff T; Zender L; Merkesdal S; Frericks B; Malek N; Bleck J; Kubicka S; Baus S; Chavan A; Manns MP; Galanski M
    World J Gastroenterol; 2005 Feb; 11(8):1091-5. PubMed ID: 15754387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.